← Back to Search

Transdiagnostic Sleep and Circadian Intervention (TranS-C), adapted for cardiac rehabilitation for Sleep Wake Disorder

N/A
Waitlist Available
Led By Caitlan A. Tighe, PhD MA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 and 6 months
Awards & highlights

Study Summary

This trial is testing a new sleep intervention for Veterans in cardiac rehab, to see if it improves sleep and other outcomes.

Eligible Conditions
  • Sleep Wake Disorder
  • Sleep Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
MacNew Heart Disease Health-Related Quality of Life Questionnaire (MacNew) from Baseline to 3 and 6 months
Multidimensional Treatment Satisfaction Measure
Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v 1.0-Sleep Disturbance 8a from Baseline to 3 and 6 months
+2 more
Secondary outcome measures
Life Space Assessment from Baseline to 3 and 6 months
Physical Performance Test (PPT)from Baseline to 3 and 6 months
Short Physical Performance Battery (SPPB) from Baseline to 3 and 6 months
+1 more
Other outcome measures
Insomnia Severity Index from Baseline to 3 and 6 months
Pittsburgh Sleep Quality Index from Baseline to 3 and 6 months

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TranS-C + Usual CareExperimental Treatment1 Intervention
Participants in this group will receive TranS-C and will continue with care in cardiac rehabilitation as usual.
Group II: Usual CareActive Control1 Intervention
Participants in this group will receive only usual care and thus will continue with care in cardiac rehabilitation as usual.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,603 Total Patients Enrolled
Caitlan A. Tighe, PhD MAPrincipal InvestigatorVA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this medical trial still ongoing?

"Indeed, according to clinicaltrials.gov, this medical experiment has resumed recruitment since it was initially posted on January 27th 2022 and revised as of August 23rd 20202. 100 individuals are needed from 1 medical centre for the trial's participation."

Answered by AI

What objectives are researchers aiming to accomplish with this trial?

"The primary endpoint of this 3-month trial is to measure the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v 1.0 - Sleep Disturbance 8a from Baseline to three and six months. Other outcomes that will be evaluated include, but are not limited to, Duke Activity Status Index (DASI), World Health Organization Quality of Life-BREF (WHOQOL-BREF), and Life Space Assessment at all time points mentioned previously."

Answered by AI

What is the total enrollment figure of this research protocol?

"Affirmative. As per records on clinicaltrials.gov, this medical research is currently recruiting patients; the trial was first posted on January 27th 2022 and most recently updated in August of that year. The aim is to enroll 100 participants at a single site."

Answered by AI
~0 spots leftby Apr 2025